Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

177
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
177
Clinical Trials01:16

Clinical Trials

10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.9K
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

298
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
298
Pharmacovigilance01:19

Pharmacovigilance

1.8K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.8K
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

231
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
231
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adverse events associated with the use of cannabis-based products in people living with cancer: a systematic scoping review.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2024
Same author

Effects of Chicory and Fumitory on Hot Flashes Among Breast Cancer Survivors: A Randomized, Double-Blind Placebo-Controlled Trial.

Journal of integrative and complementary medicine·2022
Same author

Microbial Diversity and Characteristics of Kombucha as Revealed by Metagenomic and Physicochemical Analysis.

Nutrients·2021
Same author

Zinc for the prevention or treatment of acute viral respiratory tract infections in adults: a rapid systematic review and meta-analysis of randomised controlled trials.

BMJ open·2021
Same author

Integrative Medicine in General Practice in Australia: A Mixed-Methods Study Exploring Education Pathways and Training Needs.

Global advances in health and medicine·2021
Same author

Interprofessional Communication-A Call for More Education to Ensure Cultural Competency in the Context of Traditional, Complementary, and Integrative Medicine.

Global advances in health and medicine·2021

Related Experiment Video

Updated: Feb 23, 2026

Field Identification of Matricaria chamomilla using a Portable qPCR System
12:08

Field Identification of Matricaria chamomilla using a Portable qPCR System

Published on: October 10, 2020

7.4K

Complementary medicine products: interpreting the evidence base.

Marc Cohen1, Jennifer Hunter2,3

  • 1School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria, Australia.

Internal Medicine Journal
|September 12, 2017
PubMed
Summary
This summary is machine-generated.

Many patients use complementary medicine (CM) products without informing doctors, risking adverse events and interactions. Evidence for CM safety and efficacy is growing, but clear, accessible information is needed for informed decisions.

Keywords:
complementary medicineevidence-based practiceherbal medicineintegrative medicinenutritional medicinesupplement

More Related Videos

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.7K
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.8K

Related Experiment Videos

Last Updated: Feb 23, 2026

Field Identification of Matricaria chamomilla using a Portable qPCR System
12:08

Field Identification of Matricaria chamomilla using a Portable qPCR System

Published on: October 10, 2020

7.4K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.7K
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.8K

Area of Science:

  • Integrative Medicine
  • Pharmacology
  • Public Health

Background:

  • Complementary medicine (CM) use is prevalent for self-care, often without medical consultation.
  • Growing evidence supports CM safety, efficacy, and cost-effectiveness.
  • Potential risks include adverse events, withdrawal issues, and drug interactions.

Purpose of the Study:

  • To highlight the need for accessible, evidence-based information on complementary medicine (CM) products.
  • To address challenges in interpreting CM research due to product specificity.
  • To support informed decision-making for consumers and clinicians.

Main Methods:

  • Review of current evidence on complementary medicine (CM) safety and efficacy.
  • Analysis of the Australian regulatory framework for CM products.
  • Assessment of information accessibility for consumers and healthcare providers.

Main Results:

  • CM product research is often preparation-specific, causing interpretation difficulties.
  • Regulatory oversight in Australia aligns with prescription medicines, based on risk.
  • A significant gap exists in easily understandable, evidence-based CM information.

Conclusions:

  • Consumers and clinicians require clear, evidence-based resources for informed CM use.
  • Addressing information gaps is crucial for mitigating CM risks and optimizing benefits.
  • Further research and dissemination strategies are needed to bridge the knowledge gap.